Locations:

Tag: c5research

August 29, 2023/Heart, Vascular and Thoracic/Research

Updates From CLEAR Outcomes and VALOR-HCM: Expanded Benefits With Bempedoic Acid and Mavacamten

Additional analyses of the two trials presented at 2023 ESC Congress

November 18, 2020/Heart, Vascular and Thoracic/Research

STRENGTH Results Prompt Questions About Omega-3 and Cardiovascular Risk

High-dose omega-3 fatty acid conferred no outcomes benefit over corn oil in high-risk patients

20-HVI-1915480-CQD-Ramping-up-research-after-COVID

August 6, 2020/COVID-19

Reigniting Clinical Research in the Wake of a Pandemic

Perspectives and learnings from our Heart, Vascular & Thoracic Institute

August 29, 2017/Geriatrics

PRECISION-ABPM Reveals Differential Blood Pressure Effects with Chronic Use of 3 NSAIDs

Celecoxib has least impact, followed by naproxen and ibuprofen

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

August 29, 2017/Heart, Vascular and Thoracic/Research

CETP Inhibitor Evacetrapib’s Disappointments Extend to Diabetics Too

ACCELERATE substudy shows no benefit of evacetrapib in patients with diabetes

BackPage 1 of 1Next